Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis

doi:10.5527/wjn.v5.i2.204

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6601)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

452

WORD

366

HTML

3206

Figures (1-3)

149

Tables (1-6)

164

Sum=4337

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

815

Download

1449

Sum=2264

Mar 6, 2016 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Nephrol. Mar 6, 2016; 5(2): 204-212
Published online Mar 6, 2016. doi: 10.5527/wjn.v5.i2.204

Table 1 Characteristics of peritoneal dialysis patients

Characteristics of patients
Sex (male/female)	122/96 (56% male)
Etiology (non-DM/DM)	179/36 (17% diabetes)
Age (yr)	56 (20, 46, 64, 84)
PD duration (mo)	40 (1, 15, 63, 206)
Peritonitis episode (times)	0 (0, 0, 1, 9)
D/P Cr	0.65 (0.38, 0.59, 0.71, 0.88)
D/D 0 glucose	0.40 (0.21, 0.34, 0.44, 0.59)

Data except sex and etiology of renal failure are expressed as median with minimum value, interquartile range, and maximum value. PD: Peritoneal dialysis; Cr: Creatinine; DM: Diabetes mellitus; non-DM: Non-diabetes mellitus.

Citation: Hirahara I, Kusano E, Morishita Y, Inoue M, Akimoto T, Saito O, Muto S, Nagata D. Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis. World J Nephrol 2016; 5(2): 204-212
URL: https://www.wjgnet.com/2220-6124/full/v5/i2/204.htm
DOI: https://dx.doi.org/10.5527/wjn.v5.i2.204